197 related articles for article (PubMed ID: 34804157)
1. Prognostic Value of a Pyroptosis-Related Long Noncoding RNA Signature Associated with Osteosarcoma Microenvironment.
Bu X; Liu J; Ding R; Li Z
J Oncol; 2021; 2021():2182761. PubMed ID: 34804157
[TBL] [Abstract][Full Text] [Related]
2. Machine Learning-Based Integration Develops a Pyroptosis-Related lncRNA Model to Enhance the Predicted Value of Low-Grade Glioma Patients.
Wu J; Lu L; Wang C; Jiang F
J Oncol; 2022; 2022():8164756. PubMed ID: 35646114
[TBL] [Abstract][Full Text] [Related]
3. A four-lncRNA risk signature for prognostic prediction of osteosarcoma.
Liu H; Chen C; Liu L; Wang Z
Front Genet; 2022; 13():1081478. PubMed ID: 36685868
[No Abstract] [Full Text] [Related]
4. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
Peng Y; Wang H; Huang Q; Wu J; Zhang M
J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
[TBL] [Abstract][Full Text] [Related]
5. A Novel Pyroptosis-Related lncRNAs Signature for Predicting the Prognosis of Kidney Renal Clear Cell Carcinoma and Its Associations with Immunity.
Tang X; Zhang A; Feng Y; Su Y; Wang X; Jiang F; Ma J
J Oncol; 2021; 2021():9997185. PubMed ID: 34764994
[TBL] [Abstract][Full Text] [Related]
6. Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer.
Lu H; Wu J; Liang L; Wang X; Cai H
Front Immunol; 2022; 13():803355. PubMed ID: 35154117
[TBL] [Abstract][Full Text] [Related]
7. Prognosis Risk Model Based on Pyroptosis-Related lncRNAs for Bladder Cancer.
Lu Z; Tang F; Li Z; Lai Y; Lu Z; Zhang J; Tang Z; Cai W; He Z
Dis Markers; 2022; 2022():7931393. PubMed ID: 35154513
[TBL] [Abstract][Full Text] [Related]
8. Development of a Machine Learning-Based Autophagy-Related lncRNA Signature to Improve Prognosis Prediction in Osteosarcoma Patients.
Zhang GZ; Wu ZL; Li CY; Ren EH; Yuan WH; Deng YJ; Xie QQ
Front Mol Biosci; 2021; 8():615084. PubMed ID: 34095215
[TBL] [Abstract][Full Text] [Related]
9. A five metastasis-related long noncoding RNA risk signature for osteosarcoma survival prediction.
Yu S; Shao F; Liu H; Liu Q
BMC Med Genomics; 2021 May; 14(1):124. PubMed ID: 33964903
[TBL] [Abstract][Full Text] [Related]
10. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Zhu W; Ye Z; Chen L; Liang H; Cai Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
[TBL] [Abstract][Full Text] [Related]
11. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma.
Lu Y; Luo X; Wang Q; Chen J; Zhang X; Li Y; Chen Y; Li X; Han S
Front Genet; 2022; 13():862741. PubMed ID: 35368663
[No Abstract] [Full Text] [Related]
12. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
Wu L; Liu G; He YW; Chen R; Wu ZY
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
[TBL] [Abstract][Full Text] [Related]
13. Identification and Development of an Age-Related Classification and Signature to Predict Prognosis and Immune Landscape in Osteosarcoma.
Hong J; Wang X; Yu L; Li J; Hu H; Mao W
J Oncol; 2022; 2022():5040458. PubMed ID: 36276293
[TBL] [Abstract][Full Text] [Related]
14. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.
Li L; Xie R; Lu G
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34027555
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Solute Carrier Family-Based Signature for Predicting Overall Survival in Osteosarcoma.
Zheng D; Wei Z; Guo W
Front Genet; 2022; 13():849789. PubMed ID: 35518353
[TBL] [Abstract][Full Text] [Related]
16. Construction and validation of a novel apoptosis-associated prognostic signature related to osteosarcoma metastasis and immune infiltration.
Fu Y; Jin Z; Shen Y; Zhang Z; Li M; Liu Z; He G; Wu J; Wen J; Bao Q; Wang J; Zhang W
Transl Oncol; 2022 Aug; 22():101452. PubMed ID: 35598382
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Hypoxia-Associated Prognostic Signature Related to Osteosarcoma Metastasis and Immune Infiltration.
Fu Y; Bao Q; Liu Z; He G; Wen J; Liu Q; Xu Y; Jin Z; Zhang W
Front Cell Dev Biol; 2021; 9():633607. PubMed ID: 33816483
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics analysis of lncRNAs in the occurrence and development of osteosarcoma.
Liu H; Zong C; Sun J; Li H; Qin G; Wang X; Zhu J; Yang Y; Xue Q; Liu X
Transl Pediatr; 2022 Jul; 11(7):1182-1198. PubMed ID: 35958002
[TBL] [Abstract][Full Text] [Related]
20. Exploration and Validation of a Novel Inflammatory Response-Associated Gene Signature to Predict Osteosarcoma Prognosis and Immune Infiltration.
Fu Y; He G; Liu Z; Wang J; Zhang Z; Bao Q; Wen J; Jin Z; Zhang W
J Inflamm Res; 2021; 14():6719-6734. PubMed ID: 34916821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]